Follow-up of patients with endometriosis treated with danazol
other
public-domain-us
AI-generated summary
This paper assesses the outcomes of 65 endometriosis patients treated with danazol at daily dosages of 600 mg, 400 mg, or 200 mg.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Since 1975, 65 cases of endometriosis have been treated with danazol, and in an attempt to retain effective management with a minimum of side effects, three different dosage scheme providing 600 mg (Group 1) 400 mg (Group 2) or 200 mg daily (Group 3) have been used. At present 20 cases in Group 1, 16 in Group 2 and 12 in Group 3 are available for assessment and the results are here presented.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-06-16T06:07:01.518242+00:00
- pubmed
- last seen: 2026-05-14T05:58:48.767648+00:00
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine
Courtesy of the U.S. National Library of Medicine